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Abstract
Objective: To determine if a less expensive, easier, and faster to perform HBA test is clinically equal to the
more complicated, technically challenging and expensive SPA test as a reliable indicator of sperm fertilizing
capacity.
Design: Prospective study.
Setting: Andrology laboratory within In Vitro Fertilization Program.
Patient(s): Semen samples from 26 infertility couples were analyzed. Both, normal and male factor patients
were included.
Intervention(s): Male partner screening with the HBA and the SPA tests.
Main Outcome Measure(s): Relationship between HBA and SPA test results.
Result(s): The data obtained in this study showed no statistically significant relationship between the HBA
and SPA results. The mean HBA scores 76.3%, 61.3% and 76.8% were statistically not significantly different
as compared to patients with negative (<5), grey zone (5–8) and for positive (>8) sperm capacitation index
values.
Conclusion(s): The HBA is not predictive of the results of the SPA. Therefore, HBA test does not reduce
the need for and cannot replace the SPA test in male partner screening prior to infertility treatment.
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Introduction
The most important part of the management of male infer-
tility is a correct diagnosis. The semen analysis is widely
performed as a major test of male fertility potential, by
assessing sperm count, motility and morphology of the
spermatozoa. It is clear that these parameters are not suf-
ficient alone to interpret the fertility status of an ejaculate,
unless significantly abnormal. Sperm function may not be
predicted by semen analysis, as the fertilization process
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ninvolves a large number of biochemical events not meas-
ured by these parameters. Thus, semen analysis is limited
in its inability to assess the fertilizing potential of the sam-
ple (1–5). Nearly one third of male factor infertility etiol-
ogies remain unexplained and are considered idiopathic
(6). Additional tests need to be used to indicate the func-
tional activity of spermatozoa (7,8). The sperm penetra-
tion assay (SPA) is one such test that provides additional
information for sperm fertilizing ability, using zona free
hamster oocytes (9). Unfortunately, the SPA is costly,
technically challenging, time consuming and is not readily
performed in many infertility clinics. We chose to exam-
ine a less costly, technically easier alternative for assess-
ing sperm function that could serve as a useful screening
tool to aid in the decision making process to determine
which appropriate reproductive techniques should be
used.
The hyaluronan binding assay (HBA) evaluates the matur-
ity of sperm in a fresh semen sample (10). The HBA is a
simple technique proposed as a component of the standard
semen analysis in the diagnosis of suspected male infer-
tility, to predict sperm performance and fertilization
potential. However, diagnostic use of the HBA is still
investigational. To further the understanding of the HBA
we explore the relationship between the SPA and HBA
tests. We investigate the possibility of replacing the SPA
(complicated, long and expensive) with the HBA test
(simple, short and less costly).
Materials and Methods
Patients
The study population included 26 randomly selected male
patients with a history of infertility and those who came
to andrology laboratory for a first evaluation of fertility
potential. Both, normal and male factor patients were
included. Institutional review board approved this study.
Since all tests were performed on discarded human sperm
samples which were coded to avoid any link to the donor,
no informed consents were obtained.
Study Design
Conventional semen analysis with Kruger morphology,
hyaluronan binding assay and sperm penetration assay
were performed for each male patient on the same semen
sample. Routine semen analysis parameters and Kruger
morphology values, HBA and SPA test results (SCI) for
tested 26 patients are noted in Table 1. The results are
presented as mean values (+/−) standard deviations and
range of the evaluated test values.
Conventional Semen Analysis
Ejaculates were collected by masturbation after 2–5 days
of abstinence. Each specimen after liquefaction was eval-
uated with routine semen analysis including sperm count
and motility according to guidelines from the World
Health Organization, 1999 (3). The Kruger classification
for sperm morphology was also recorded (11).
Hyaluronan Binding Assay (HBA)
Semen samples from 26 infertility patients were also tes-
ted with HBA (Biocoat, INC, Ft. Washington, PA, USA),
following the manufacturer’s instructions. Each HBA
slide had two identical chambers with a molecular layer
of hyaluronan covalently attached to the chamber surface.
These slides are for determination of the hyaluronan-bind-
ing fraction of motile sperm in a semen sample. Mature,
motile sperm bind with hyaluronan through specific
receptors. We applied 10 μl of semen to a chamber and
installed a cover slip, incubated for 10 minutes, at room
temperature (18–28ºC) to allow for complete binding.
Then under a microscope we counted the numbers of
bound and unbound motile sperm in the same number of
grid squares, in the same sample volume. Bound motile
sperm appeared on the slide showing rapidly beating tails,
but their heads showed no forward, progressive move-
ment, while unbound motile sperm swam around freely.
The HBA score (%) was calculated as # bound motile
sperm / # total motile sperm. The value of the HBA is
based on the proposition that a low level of sperm binding
to hyaluronan is suggestive that there is a low proportion
of mature sperm in the sample (10).
Methodology of Sperm Penetration Assay (SPA)
The SPA is a multi-step, two day laboratory test. On day
one of SPA we used basic method of processing sperm,
mixing and overnight incubation in the Test Yolk buffer
refrigeration medium (Irvine Scientific, Santa Ana, CA,
Table 1. 
Semen parameters for sample population
Parameter
  Mean+/− SD
  Range
 
Count ( × 10
6) 67.78 +/− 53.59 221 - 4.8
% Motility 70.54 +/− 22.73 98 - 23
Total motile 142.26 +/− 130.13 469.6 - 6.3
Kruger morphology (%) 11.85 +/− 4.45 20 - 2
SCI results 10.68 +/− 7.32 23.4 - 0
HBA score (%)
  74.85 +/− 15.64
  97 - 26
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nUSA) at 4ºC for 18–20 hours, to slowly effect and induce
capacitation (12). On day two of SPA, after sperm capaci-
tated during overnight storage, it was warmed to 37ºC i.e.
thermal shocked (12), and sperm concentration was adjus-
ted. On day two of SPA, zona free hamster oocytes were
prepared by enzymatic digestion, washed and allowed to
incubate 3 hours with sperm at 37ºC under 5% CO2,
before determining the percentage of eggs penetrated and
the number of sperm penetrations per egg.
Day One of Sperm Penetration Assay (SPA)
Semen samples were prepared for SPA testing by per-
forming a sperm gradient (45/90) Isolate (Irvine Scien-
tific, Santa Ana, CA, USA) and two washes with IVC (In
Vitro Care, Frederick, MD, USA) Human Tubal Fluid
(HTF) - Hepes with 10% IVC Human Serum Albumin
(HSA). The washed sample was mixed with an equal vol-
ume of Test Yolk buffer refrigeration medium and was
incubated overnight in the refrigerator at 4ºC for 18–20
hours to allow capacitation.
Day Two of Sperm Penetration Assay
Preparation of Sperm—Following the incubation
period, supernatant was removed, and the pellet was resus-
pended in 2.0 ml of warmed IVC HTF Hepes with 10%
HSA (thermal shock) and centrifuged at 300g for 10
minutes. The supernatant was discarded. The pellet was
resuspended in 0.1 – 1.0 ml of IVC HTF with 10% HSA
and placed in the incubator for 30–60 minutes. An SPA
control semen specimen was run in parallel.
Preparation of Zona – Free Hamster Oocytes—On
day two of SPA hamster oocytes were thawed according
to Embryotech Laboratories INC., (Wilmington, MA,
USA) package instructions. Hamster oocytes zona were
removed for 30–60 seconds at room temperature in 1mg/
ml Trypsin (Sigma-Aldrich Corp, St. Louis, MO, USA)
and rinsed thoroughly in IVC HTF Hepes with 10% HSA.
The 15 zona-free hamster oocytes per dish were insemi-
nated with 3 million motile sperm and placed in the incu-
bator for 3–3.5 hours. After the incubation period any
loosely bound sperm were removed. Oocytes were placed
in the polyvinylpyrrolidone-PVP (IVF online.com, Guil-
ford, CT, USA) drops on the microscope glass slide. A
24X40 glass cover slip was carefully placed over PVP
drops, without entrapping air bubbles. Swollen sperm
heads with attached tails were scored as penetrations in
each oocyte using Nikon Labophot-2 Light Microscope
(40X objective). Sperm capacitation index (SCI) was cal-
culated as the total number of sperm penetrations divided
by the number of hamster oocytes analyzed. Normal val-
ues established in our laboratory were SCI <5 (negative
score), <5 SCI <8 (gray zone) and SCI >8 (positive score).
Statistical Analysis—Significance was tested by linear
regression, Student’s t-test and the Mann-Whitney U
(Mann-Whitney-Wilcoxon) test, with the latter two tests
performed using two different cut-off points (SCI=5 and
SCI=8).
Results
Linear regression analysis (Figure 1) showed no statisti-
cally significant relationship between HBA and SPA
results (R2=0.02, F= 0.51, p=0.48). The mean HBA scores
were 76.3%, 61.3% and 76.8% for the patients with neg-
ative (n=8), grey zone (n=3) and for positive (n=15) SCI
values, respectively. Student’s t-test and the MWW test
showed no statistically significant difference between the
two pairs of sample means. Taking 5 as the SCI cut-off
value, the mean difference between the corresponding
HBA sample scores (n1=8, n2= 18) is 2.03 with t=0.30
and p=0.77 (MWW test: z= −0.11 and p=0.91). When the
SCI cut-off value is set to 8, the mean difference between
the two samples (n1=11, n2=15) is −4.62 with t=−0.74
and p=0.47 (MWW test: z= −0.65 and p=0.52).
Discussion
Sperm capacitation index – SCI, (the average number of
sperm penetrations per hamster egg), was compared with
HBA scores, (the number of mature sperm in percent), for
26 patients. Correlation between SPA and HBA tests
would be recognized if patients with higher SPA scores
had higher HBA scores. However, in our lowest SPA score
group (negative SCI<5), the mean HBA score was 76.3%,
similar to the HBA score of 76.8% in our highest SPA
score group (positive SCI >8). The present study showed
that the HBA was not significantly correlated with the
SPA results as analyzed by linear regression, Student’s t-
test and the Mann-Whitney U (MWW) test.
In order to promote better understanding of our results we
briefly explain some of the complicated events involved
in the fertilization process. Fertilization occurs when a
sperm fuses with an egg to form a zygote (13,14). Sperm
must first be capacitated; that is, their membranes must
become fragile so that the hydrolytic enzymes in their
acrosomes can be released during acrosome reaction
(13,15). Capacitation requires separation of sperm from
seminal plasma, followed by incubation for a defined
period in the female tract or an appropriate laboratory
medium (16) when spermatozoa undergo a series of bio-
chemical transformations. The ovulated oocyte is encap-
sulated by the corona radiata and zona pellucida, both of
which must be breached before the oocyte itself can be
penetrated (13). After breaching the corona, the sperm
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nhead binds to the ZP3 glycoprotein of the zona pellucida
and causes a rise in Ca2+ level within the sperm that trig-
gers the acrosomal reaction (13). Hundreds of sperm acro-
somes must rupture to break down the intercellular
cement, rich in hyaluronic acid, that holds the granulosa
cells together and to digest holes in the zona pelucida
(13). Once a path has been cleared and a single sperm
makes contact with the oocyte’s membrane receptors,
their plasma membranes fuse, allowing sperm nucleus to
be pulled into the oocyte’s cytoplasm and chromatin
decondensation occurs (13).
The SPA test, in determining the ability of sperm to pen-
etrate zona-free hamster eggs directly, addresses four dis-
crete physiological steps in the process of fertilization:
capacitation, acrosome reaction, fusion with and penetra-
tion through the oolemma, and decondensation within the
cytoplasm of an oocyte (9)
Sperm oocyte fusion in the hamster oocyte penetration test
differs from the physiological situation in that the zona
pellucida is absent (3). The conventional hamster oocyte
test depends upon the occurrence of spontaneous acro-
some reactions in populations of spermatozoa incubated
for prolonged periods of time in vitro (3).
Preincubation in TEST-yolk buffer at 4ºC makes sperma-
tozoa highly fusogenic, enhancing sperm penetration (17).
As hypothesized by Mortimer (18), incubation in TEST-
yolk buffer at low temperature promotes intracellular
accumulation of Ca2+ ions, due to a reduced activity of
calcium pump; moreover, the egg yolk phospholipids
intercalate into membranes, making the spermatozoa
highly labile. However, acrosome reactions are prevented
by low temperature. Hence, upon restoring physiological
temperature, the elevated Ca2+ concentrations trigger
synchronized acrosome reactions, enhancing sperm pen-
etration (18).
The SPA preparation method with Test-yolk technique
correlates well with fertility (12,17) and with the outcome
of IVF (19).
The SPA has been used for many years for diagnosing and
implementing appropriate infertility treatment (19,20,21).
The SPA allows an important differentiation between
patients who can have conventional in vitro insemination-
IVF and those who require intracytoplasmic sperm injec-
tion-ICSI (22). For many couples with a normal semen
analysis and SPA test, maximal fertilization can be ach-
ieved with conventional insemination (22). ICSI was
introduced as a treatment for severe male infertility. How-
ever, some centers consider that ICSI rather than IVF
should be offered as the treatment of choice to all cases
requiring assisted reproduction (23).
There are numerous studies done on children born after
ICSI that have looked at the potential effects of ICSI, with
differing conclusions (24,25,26,27). Since the studies are
not in agreement, perhaps the safest assumption is that
ICSI is not to be used until conventional insemination is
highly unlikely to succeed (28).
Even though SPA may be a useful technique for predicting
appropriate treatment options (22), widespread adoption
Figure 1.  Linear regression analysis of SPA (SCI results) compared with HBA scores (%)
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nof the SPA test has been limited due to the lack of stand-
ardization of SPA protocols and experimental conditions
among centers (2,29). Typical capacitation time for sperm
incubation before the SPA is 18–20 hours (9). Therefore,
inconsistent SPA results may be due to inappropriately
short capacitation times (30,31). Whether due to extreme
complexity, cost, or questionable reliability, the reality is
that the SPA test is rarely performed in infertility clinics.
HBA has recently been marketed as an addition to semen
analysis for predicting sperm fertilizing ability. Although
its clinical value is still investigational, HBA is becoming
a more popular test in many ART clinics worldwide (32).
While SPA evaluates multiple steps that lead to fertiliza-
tion, HBA is limited to the step before acrosome reaction
(AR). Even though the SPA test evaluates acrosome reac-
tion only indirectly, the HBA assesses HA-bound sperm
which have intact acrosomes that have not undergone AR
(10). After sperm capacitation any of the remaining steps
that lead to fertilization can fail. The HBA test cannot
predict failure of post capacitation events as the SPA can,
since the purpose of SPA is to evaluate sperm fusion and
decondensation as consequence of capacitation.
Previous publications have suggested that HBA may be a
useful additional test to the semen analysis and the SPA
test (10). The semen analysis and SPA can help give a
definitive diagnosis of male infertility and HBA can be an
important tool in selecting the best quality sperm used in
ICSI. There is a known relationship between HA bound
sperm and enhanced levels of developmental sperm
maturity, including fewer chromosomal aberrations and
higher sperm DNA integrity (10). Recently the FDA
approved a device in which the HBA test serves as a tool
in assisting an embryologist in selecting mature sperm for
ICSI based on sperm binding to hyaluronan, the main
constituent of the cumulus oophorous surrounding the
oocyte.
Although we used small numbers of patients, data
obtained from this study do not tend to support the possi-
bility that HBA can replace SPA. Recently it has been
found that the clinical predictive value of HBA for sperm
fertilizing ability in vitro is limited and that HBA does not
provide additional information for identifying patients
with a poor fertilization rate (32). In their study Hong et
al. outlined that HBA is not superior to the routine semen
analysis for predicting sperm fertilizing ability (32). Free-
man et al. however, concluded that SPA is a more sensitive
screening tool for the prediction of IVF fertilization than
the semen analysis alone (22). Furthermore in their hands
the SPA test was accurate in predicting fertilization rates
in IVF when performed with standardized procedures and
appropriate capacitation time (22). Multiple other groups
have confirmed that SPA is a reliable assay for determin-
ing the fertilizing ability of human spermatozoa (33–39).
We conclude that since HBA scores do not correlate with
SPA results, the HBA test does not reduce the need for
(and cannot replace) the SPA test in male partner screen-
ing prior to infertility treatment.
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